Led by JY Bonnefoy, PhD, a serial entrepreneur experienced in oncology R&D from bench to patients, both with big pharmas and start-ups, Salto Therapeutics is focusing on new treatments for rare pediatric cancers. Our business model is to in-license early stage assets and to develop them in the clinic targeting approvals in the US & EU. We are currently operating in a stealth mode.
